Clinical trial · Observational
A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer
NCT05086601CI-TRIAL-00054592unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to establish a colorectal cancer cohort, collect clinicopathological information, collect biological samples for multi-omics testing, and perform relevant analysis, to predict the prognosis of colorectal cancer, guide the diagnosis and treatment of colorectal cancer and the formulation of health policies.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| colorectal cancer surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Disease-free survival time
- timeFrame
- 2 yeas after surgery
- description
- For patients received radical resection of colorectal cancer, disease-free survival time is defined as time from the surgery to any recurrence of disease or death, recorded in months.
Secondary outcomes (2)
- measure
- Overall survival time
- timeFrame
- 2 yeas after surgery
- description
- Overall survival time is defined as time from the surgery to death, recorded in months.
- measure
- Pathological TNM stage
- timeFrame
- 1 month after surgery
- description
- The pathological TNM stage included the pathological T stage, pathological N stage and M stage. The pathological T and N stage is decided according to the removed specimen of the primary tumor by the pathologist after surgery. The M stage is decided according to the imaging tests as CT, MRI and PET-CT.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Pathologically diagnosed as colorectal cancer * Receiving any surgery of primary tumor, including palliative resection, simple enterostomy and exploratory surgery Exclusion Criteria: * The patient refused to join the study * The patient refused to collect the biological sample * The patient refused to follow up
References
Publications (0)
Data not yet available
No reference posted for this study.